Artificial intelligence is entering the era of self-improvement. On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation.

Google’s Veo video AI made stunning leaps in fidelity in 2025, and Google isn’t stopping in 2026. The company has announced an update for Veo 3.1 that adds new capabilities when you provide the model ...

Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes ...

After days of storms throughout Christmas week, several Southern California communities are dealing with storm damage from the rain, high winds, flooding and mudslides. The National Weather Service ...

It's quick and easy to access Live Science Plus, simply enter your email below. We'll send you a confirmation and sign you up for our daily newsletter, keeping you up to date with the latest science ...

OnlyFans model and murder defendant, Courtney Clenney, right, appears in court as her defense lawyer argued that the Miami-Dade States Attorney’s Office should be disqualified following the exit of ...

An OnlyFans model accused in one of Miami’s most closely watched criminal cases will head to trial next spring, after a judge again declined to release her from custody. According to The Miami Herald, ...

Mass General Brigham has announced the development of an AI company and screening tool that has sped up the process for determining a patient’s eligibility and enrollment for clinical trials.

The second week of one of the most consequential trials in NASCAR history begins Monday morning. Here’s a reminder of what’s at stake and what has happened so far after the first week of proceedings ...

Courtney Clenney, an OnlyFans model, faces trial in December for the 2022 stabbing death of Christian Obumseli. Prosecutors allege a toxic relationship led to murder, while Clenney claims self-defense ...

Approximately half the worldwide population is at risk for dengue. No antiviral prophylaxis or treatment options are available. In a phase 2a, double-blind, randomized trial, we assigned healthy ...